Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Next-Gen Sequencing Europe

Francesca Ciccarelli's Biography



Francesca Ciccarelli, Group Leader, European Institute of Oncology Milan

Francesca Ciccarelli is Principal Investigator at the European Institute of Oncology (Milan). She graduated in Pharmaceutical Chemistry at the University of Bologna and obtained the PhD in Natural Science at the University of Heidelberg. She has been research assistant in the computational biology group led by Peer Bork at the EMBL from 2001 to mid 2005.
Dr. Ciccarelli has an extensive expertise in comparative and evolutionary genomics, which she now applies to discover the genetic determinant of cancer. Her lab focuses on the discovery of variants associated to cancer development using next generation sequencing. In particular, they are interested in detecting rare mutations to measure genome instability and rebuild the evolution of individual tumors.

Francesca Ciccarelli Image

Genomic Instability and the Evolution of Cancer

Thursday, 30 June 2011 at 11:45

Add to Calendar ▼2011-06-30 11:45:002011-06-30 12:45:00Europe/LondonGenomic Instability and the Evolution of CancerSELECTBIOenquiries@selectbiosciences.com

Cancer is often associated to genomic instability, defined as the dynamic acquisition and propagation of genomic modifications. In several cases these modifications are causally implicated in the initiation and development of the disease. The latest improvements in sequencing technologies have boosted the discovery of cancer-associated modifications, thus allowing the investigation of several aspects of cancer genomic instability. In this talk, our contribution to the understanding of the genetic and genomic determinants of cancer will be presented. Particular emphasis will be laid on the properties of genes whose mutations are causally implicated in cancer and on the detection of cancer-associated genomic instability.


Add to Calendar ▼2011-06-30 00:00:002011-07-01 00:00:00Europe/LondonNext-Gen Sequencing EuropeSELECTBIOenquiries@selectbiosciences.com